Chhabi Lal Chaudhary

Dr. Chhabi Lal Chaudhary

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 February 2022 in Green Chemistry
Verified
Journal Article
Closed access
PDF file
CJChanhyun Jung
Chanhyun Jung
SLSiyuan Li
Siyuan Li
KLKwanghee Lee
Kwanghee Lee
MVMAYAVAN VIJI
MAYAVAN VIJI
HLHeesoon Lee
Heesoon Lee
JJJae-Kyung Jung
Jae-Kyung Jung
Solvent-directed intramolecular hydrofunctionalization of readily available o -alkynoylphenols 1 was successfully achieved under reagent-free conditions.

24 March 2022 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
CCChhabi Lal Chaudhary
Chhabi Lal Chaudhary
SKSeungyun Ko
Seungyun Ko
CLChaerim Lee
Chaerim Lee
YKYerin Kim
Yerin Kim
CJChanhyun Jung
Chanhyun Jung
HLHeesoon Lee
Heesoon Lee
With the several targets of cancer treatment, inhibition of DNA topoisomerase activity is one of the well-known focuses in cancer chemotherapy. Here, we describe the design and synthesis of a novel series of pyrazolo[4,3-f]quinolines with potential anticancer/topoisomerase inhibition activity. Forty newly designed pyrazolo[4,3-f]quinoline derivatives were synthesized via inverse imino Diels–Alder reaction. The antiproliferative activity of the synthesized derivatives was initially measured in the human NUGC-3 cancer cell line. Then, the selected compounds 1B, 1C, 1M, 2A, 2D, 2E, 2F, and 2R with higher activity among tested compounds were screened against six cancer cell lines, including ACHN, HCT-15, MM231, NCI-H23, NUGC-3, and PC-3. The results demonstrated that the compounds 1M, 2E, and 2P were most effective in all cancer cell lines exhibiting GI50 below 8 µM. Among them, 2E showed an equivalent inhibition pattern of topoisomerase IIα activity to that of etoposide, positive control at a 100 µM dose.

17 November 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
JSJaeuk Sim
Jaeuk Sim
SLSrinu Lanka
Srinu Lanka
JJJeong-Woong Jo
Jeong-Woong Jo
CCChhabi Lal Chaudhary
Chhabi Lal Chaudhary
MVManjunatha Vishwanath
Manjunatha Vishwanath
JJJae-Kyung Jung
Jae-Kyung Jung
In continuation of studies for α-MSH stimulated melanogenesis inhibitors, we have evaluated the design, synthesis, and activity of a new series of chlorogenic acid (CGA) analogues comprising pyridine, pyrimidine, and diacyl derivatives. Among nineteen synthesized compounds, most of them (fifteen) exhibited better inhibitions of melanin formation in B16 melanoma cells. The results illustrated that a pyridine analogue 6f and a diacyl derivative 13a of CGA showed superior inhibition profiles (IC50: 2.5 ± 0.7 μM and 1.1 ± 0.1 μM, respectively) of α-MSH activities than positive controls, kojic acid and arbutin (IC50: 54 ± 1.5 μM and 380 ± 9.5 μM, respectively). The SAR studies showed that both –CF3 and –Cl groups exhibited better inhibition at the meta position on benzylamine than their ortho and para positions. In addition, the stability of diacyl analogues of CGA in methanol monitored by HPLC for 28 days indicated the steric bulkiness of acyl substituents as a key factor in their stability.